Multi-Center Prospective Evaluation of the Beckman Coulter Access HCV Ab Assay as an Aid in the Presumptive Diagnosis of HCV Infection: Subject Enrollment
-
- STATUS
- Not Recruiting
Summary
The purpose of this study is to evaluate the clinical performance of the Access HCV Ab Assay on the next generation immunoassay analyzer, the Dxl 9000, as an aid in the presumptive diagnosis of hepatitis C virus infection in patients at increased risk (at-risk) or with signs and symptoms of HCV infraction based on current CDC testing recommendations.
Description
The purpose of this study is to evaluate the clinical performance of the Access HCV Ab Assay on the next generation immunoassay analyzer, the Dxl 9000, as an aid in the presumptive diagnosis of hepatitis C virus infection in patients at increased risk (at-risk) or with signs and symptoms of HCV infraction based on current CDC testing recommendations.
Details
| Condition | HCV |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX9386 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.